Literature DB >> 10767364

Identification of occult micrometastases in patients with early gastric cancer using anti-cytokeratin monoclonal antibodies.

L Saragoni1, M Gaudio, P Morgagni, S Folli, F Bazzocchi, E Scarpi, A Saragoni.   

Abstract

The presence of occult micrometastases was evaluated in 1488 lymph nodes removed from 139 patients with node-negative early gastric cancer (EGC). Additional multiple levels of the lymph nodes were examined with haematoxylin-eosin staining and keratin immunostaining. Occult nodal micrometastases were detected in 24 patients (17%) in one or more lymph nodes dissected after a gastrectomy. The cases investigated were a small group from a total of 412 EGC patients who underwent surgical treatment in our hospital between 1976 and 1997; the mean follow-up period was 9 years (range 1-22). We found no significant differences between cytokeratin-negative and positive patients regarding the following clinicopathological parameters: age, gender, tumour size and site, macroscopic and microscopic type, depth of invasion and type of infiltration, according to Kodama's classification. The survival rate at 5 years was 88% and 87% for cytokeratin-negative and positive patients, respectively (log-rank = 0.6; ns). Our data suggest that occult micrometastases do not add useful information and immunohistochemical studies to detect them are probably unnecessary.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10767364     DOI: 10.3892/or.7.3.535

Source DB:  PubMed          Journal:  Oncol Rep        ISSN: 1021-335X            Impact factor:   3.906


  8 in total

1.  Lymph node, peritoneal and bone marrow micrometastases in gastric cancer: Their clinical significance.

Authors:  John Griniatsos; Othon Michail; Nikoletta Dimitriou; Ioannis Karavokyros
Journal:  World J Gastrointest Oncol       Date:  2012-02-15

Review 2.  [Minimal residual tumor in gastrointestinal carcinoma. Relevance to prognosis and oncologic surgical consequences].

Authors:  S Gretschel; A Bembenek; T Schulze; W Kemmner; P M Schlag
Journal:  Chirurg       Date:  2006-12       Impact factor: 0.955

3.  Intraoperative diagnosis of lymph node metastasis by transcription-reverse transcription concerted reaction assay in gastric cancer.

Authors:  Ryouichi Hirayama; Akiyoshi Seshimo; Kunitomo Miyake; Masako Nishizawa; Shingo Kameoka
Journal:  Int J Clin Oncol       Date:  2013-06-14       Impact factor: 3.402

Review 4.  Detection and clinical implications of minimal residual disease in gastro-intestinal cancer.

Authors:  Fabian Wolfrum; Ilka Vogel; Fred Fändrich; Holger Kalthoff
Journal:  Langenbecks Arch Surg       Date:  2005-07-01       Impact factor: 3.445

5.  Assessment of lymph node micrometastasis in early gastric cancer in relation to sentinel nodes.

Authors:  Kunitomo Miyake; Akiyoshi Seshimo; Shingo Kameoka
Journal:  Gastric Cancer       Date:  2006       Impact factor: 7.370

6.  Lymph node micrometastasis and its correlation with MMP-2 expression in gastric carcinoma.

Authors:  Ze-Yu Wu; Jing-Hua Li; Wen-Hua Zhan; Yu-Long He
Journal:  World J Gastroenterol       Date:  2006-05-14       Impact factor: 5.742

7.  Significance of isolated tumor cells in lymph nodes among gastric cancer patients.

Authors:  Olaf Horstmann; Laszlo Füzesi; Peter M Markus; Carola Werner; Heinz Becker
Journal:  J Cancer Res Clin Oncol       Date:  2004-09-17       Impact factor: 4.553

8.  Evaluation of focused sentinel lymph node RT-qPCR screening for micrometastases with the use of the Maruyama computer program.

Authors:  T Jagric; S Potrc; A Ivanecz; M Horvat; M Plankl; T Mars
Journal:  Eur Surg       Date:  2013-08-17       Impact factor: 0.953

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.